Brightstone Venture Capital


Brightstone Venture Capital manages a $100 million venture fund focused on early-growth stage investments. The firm invests primarily in Technology and Life Sciences sectors and leverages the operating experience and investment background of its partners to support portfolio companies.

Brightstone Venture Capital

Minneapolis, Minnesota, United States, North America


Services

Equity investments (early-growth stage)

Provides capital through the Fund for early-growth stage companies across technology and life sciences.

Board / director roles and portfolio management

Partners hold corporate board director/advisor roles and provide portfolio management based on multi-decade operating and board experience.

Sector expertise and advisor network

Access to an advisor network covering IT/cloud, healthcare, EAS/SaaS, dermatology, AI/ML, MedTech and UX/UI.


Portfolio

Recently raised $80M in a Series D funding.

#Virtual reality / social VR

Company completed an IPO on NASDAQ (CELC).

#Cellular diagnostics / personalized medicine

$321 million sale to WAITR Holdings (NASDAQ WTRH).

#Food delivery / logistics marketplace

Provides iPS-based micro-organ platforms for drug toxicity and efficacy testing; IPO on NASDAQ (VYNT).

#Stem cell technologies / drug testing platforms

Described as a cloud storage platform; recently raised $112M in a Series C funding.

#Cloud storage / infrastructure

Delivers SSD controllers with host-based FTL and Ethernet I/O; recently raised $10M in a Series G funding.

#Semiconductor / SSD controller IP

View All Portfolio Items

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.